3 reasons Gaithersburg's OpGen sees a major market as hospitals battle ‘superbugs’

Hospitals see a serious problem when it comes to handling antibiotic-resistant “superbug” outbreaks. Gaithersburg’s OpGen Inc. sees dollar signs.

Company officials revealed last week they hope to raise as much as $37.4 million in an initial public offering. A big reason is what OpGen estimates to be an $800 million U.S. market for hospital-acquired infections screening.

“OpGen intends to transform infectious disease management,” executives said in the company’s S-1 filing with the Securities and…